v3.26.3
EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2026
Jun. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2025
Net Income for Earnings Per Share Calculations:                
Income from continuing operations, net of tax $ 301.4     $ 292.3     $ 923.5 $ 991.8
Loss from discontinued operations, net of tax 0.0     (2.0)     0.0 (13.6)
Net income 301.4 $ 241.4 $ 380.7 290.3 $ 331.5 $ 356.4 923.5 978.2
Less: Net loss attributable to noncontrolling interest (6.1)     (0.8)     (6.6) (4.1)
Net income attributable to Edwards Lifesciences Corporation $ 307.5     $ 291.1     $ 930.1 $ 982.3
Weighted Average Shares:                
Basic weighted-average shares outstanding (in shares) 576.3     584.7     577.3 586.2
Dilutive effect of stock plans (in shares) 1.3     1.0     1.3 1.0
Dilutive weighted-average shares outstanding (in shares) 577.6     585.7     578.6 587.2
Basic:                
Continuing operations (in dollars per share) $ 0.53     $ 0.50     $ 1.61 $ 1.70
Discontinued operations (in dollars per share) 0     0     0 (0.02)
Basic earnings per share (in dollars per share) 0.53     0.50     1.61 1.68
Diluted:                
Continuing operations (in dollars per share) 0.53     0.50     1.61 1.70
Discontinued operations (in dollars per share) 0     0     0 (0.03)
Diluted earnings per share (in dollars per share) $ 0.53     $ 0.50     $ 1.61 $ 1.67